Related Experiment Video
Updated: Aug 6, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Low-Grade Sweat Gland Carcinomas: A Review-A CME Article
Kim Harnisch1,2, Antonina Kalmykova3, Phillip McKee4
1Physician, Department of Pathology and Molecular Pathology, University Hospital, Zurich, Switzerland.
Background:
Primary cutaneous adnexal carcinomas (PCACs) are rare and biologically heterogeneous neoplasms that present significant diagnostic and therapeutic challenges. Among them, microcystic adnexal carcinoma (MAC), syringoid eccrine carcinoma (SEC), primary cutaneous adenoid cystic carcinoma (PCACC), secretory carcinoma, apocrine cribriform carcinoma (PCCAC), primary cutaneous mucinous carcinoma, and neuro-endocrine mucin-producing sweat gland carcinoma are clinically and histologically distinctive yet frequently confused with one another.
Objective:
To synthesize and critically appraise current evidence on the clinicopathological, immunophenotypic, and molecular hallmarks of the 7 PCAC entities and to translate this knowledge into practical diagnostic and management guidance for dermatopathologists and oncologists.
Methods:
A narrative review of the English-language literature was conducted using PubMed/MEDLINE without date restriction. Search terms combined tumor-specific headings with keywords for epidemiology, histology, immunohistochemistry, molecular genetics, and management. Eligible articles included original studies, systematic reviews, and relevant case series describing MAC, SEC, PCACC, secretory carcinoma, PCCAC, endocrine mucin-producing sweat-gland carcinoma, or primary cutaneous mucinous carcinoma.
Results:
Distinct architectural patterns together with a focused immunohistochemical panel (eg, Ber-EP4-/EMA+ in MAC, K77+ in SEC, CD117/MYB+ in PCACC, pan-TRK+ in secretory carcinoma) and key molecular signatures (TP53/JAK1, MYB-NFIB, ETV6-NTRK3) reliably discriminate the 7 major low-grade sweat gland carcinomas. These insights translate directly into management, guiding Mohs surgery for the infiltrative, nerve-tracking tumors and enabling tropomyosin receptor kinase inhibitor therapy for advanced secretory carcinoma.
Conclusions:
Accurate recognition of PCACs requires integrative interpretation of morphology, immunoprofiles, and molecular findings supported by deep, full-thickness biopsy. Awareness of entity-specific patterns reduces misdiagnosis, guides appropriate surgical margins, and informs the selective use of ancillary testing and targeted therapies.
Related Concept Videos
Accessory Structures of the Skin: Sweat Glands
Sweat glands are classified as merocrine glands; that is, the secretions are excreted by exocytosis through a duct without affecting the cells of the gland. There...
Cellular Adaptation IV: Dysplasia and Metaplasia
Graves' Disease I: Introduction
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Accessory Structures of the Skin: Sebaceous Glands
These glands that produce the oils on the skin and hair are holocrine glands. The mature...